IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Regeneron Pharmaceuticals Inc

CUSIP: 75886F908 | 1 institutional holders

Quarters

Q3 2014Q1 2014Q3 2013
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile